https://www.gensight-biologics.com/
GenSight Biologics – Leader in Gene Therapy Against Blindness
gene therapygensightbiologicsleaderblindness
https://www.nasdaq.com/market-activity/stocks/gsgtf/insider-activity
GenSight Biologics S.A. (GSGTF) Insider Activity | Nasdaq
Find the latest information on GenSight Biologics S.A. (GSGTF) insider activity and insider shares traded to make sound investments with Nasdaq.com.
s ainsider activitygensightbiologicsnasdaq
https://www.biospace.com/gensight-biologics-announces-1-year-safety-data-and-efficacy-signals-from-pioneer-phase-i-ii-clinical-trial-of-gs030-an-optogenetic-treatment-candidate-for-retinitis-pigmentosa
GenSight Biologics Announces 1 Year Safety Data and Efficacy Signals from PIONEER Phase I/II...
Feb 13, 2023 - GenSight Biologics announced favorable safety data and encouraging efficacy signals at 1 year post-gene therapy administration for the PIONEER Phase I/II...
https://www.businesswire.com/news/home/20250123773001/en/GenSight-Biologics-Reports-End-of-Year-Cash-Position-and-Provides-Business-Update
GenSight Biologics Reports End-of-Year Cash Position and Provides Business Update
Regulatory News: GenSight Biologics ("GenSight Biologics" or the "Company") (Euronext: SIGHT, ISIN: FR0013183985, PEA-PME eligible), a biopharma company focu...
end of year
https://www.businesswire.com/news/home/20260407657670/en/GenSight-Biologics-Reports-Cash-Position-and-Revenue-from-Early-Access-Program-as-of-March-31-2026
GenSight Biologics Reports Cash Position and Revenue from Early Access Program as of March 31, 2026
Regulatory News: GenSight Biologics (Euronext: SIGHT, ISIN: FR0013183985, PEA-PME eligible), a biopharma company focused on developing and commercializing in...
https://www.nasdaq.com/market-activity/stocks/gsgtf/advanced-charting
GenSight Biologics S.A. (GSGTF) Advanced Charting | Nasdaq
GenSight Biologics S.A. (GSGTF) interactive stock charts, quotes, and comparrisons for US and global markets. No one knows the market like Nasdaq.
s aadvanced chartinggensightbiologicsnasdaq
https://www.eib.org/en/projects/all/20210328
GENSIGHT BIOLOGICS (EGFF)
The project concerns the development of the counterpart's pipeline of proprietary gene therapy candidates to provide patients with a long-lasting cure for...
gensightbiologicsegff